ANN ARBOR, MI--(Marketwire - October 06, 2008) - Pipex Pharmaceuticals, Inc. (AMEX: PP), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of autoimmune and central nervous system diseases, announces that it will present at the Maxim Group Growth Conference on Tuesday, October 7, at 9:30 a.m. EDT at the Grand Hyatt Hotel in New York City.
